Edesa Biotech, Inc.

NASDAQ:EDSA

Biotechnology

Healthcare
$5.75 +1.31%

+$0.09 today

Market cap
$55.39M
Beta
1.07
P/E (TTM)
-5.5
EPS (TTM)
-$1.27
52W Low $0.72High $20.32

Volume 0.07M

Average 0.62M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$7.91M

FY 2025 · Annual

Net Income

-$7.19M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue00000
Cost of Revenue118.79K118.19K183.47K186.05K119.27K
Gross Profit(118.79K)(118.19K)(183.47K)(186.05K)(119.27K)
Gross Margin—————
Research & Development17.95M13.34M4.79M2.88M3.67M
Selling, General & Admin5.73M5.04M4.43M4.13M4.24M
Operating Expenses23.68M18.37M9.22M7.01M7.79M
Depreciation & Amortization118.79K118.19K183.47K186.05K119.27K
EBITDA(13.22M)(17.43M)(8.19M)(5.98M)(7.07M)
EBITDA Margin—————
Operating Income(23.68M)(18.37M)(9.22M)(7.01M)(7.91M)
Operating Margin—————
Interest Income11.17K64289.85K153.5K2.56K
Interest Expense00000
Other Income / Expenses10.34M822.67K849.14K845.5K726.84K
Income Before Tax(13.34M)(17.55M)(8.37M)(6.17M)(7.18M)
Pre-Tax Margin—————
Income Tax Expense800800800800800
Net Income(13.34M)(17.55M)(8.37M)(6.17M)(7.19M)
Net Margin—————
EPS (Basic)(7.74)(8.37)(2.93)(1.93)(1.27)
EPS (Diluted)(7.73)(8.37)(2.93)(1.93)(1.27)
Weighted Avg Shares1.73M2.1M2.86M3.2M5.68M
Weighted Avg Shares (Diluted)1.73M2.1M2.86M3.2M5.68M

EDSA Earnings Waterfall · TTM

NASDAQ:EDSA · Revenue to Net Income

Key Ratios

EPS$-1.35
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-2.0
P/S Ratio0.0

Analysis

$0 of revenue converted into -$10.4M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.35, tying the income statement back to per-share earnings.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipAug 4, 2026
EFFECTEFFECT filingJul 13, 2026
424B3424B3 filingJul 13, 2026
4Statement of changes in beneficial ownershipJul 2, 2026
S-3S-3 filingJul 2, 2026

How much revenue does EDSA generate?

Edesa Biotech, Inc. (EDSA) reported $0.00 of revenue in fiscal 2025.

Is EDSA profitable?

Edesa Biotech, Inc. (EDSA) reported -$7.19M of net income.